Completed PHASE3 INTERVENTIONAL 2-arm NCT01123512

The Kiva® System as a Vertebral Augmentation Treatment (KAST)

The Kiva® System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial

Sponsor: Benvenue Medical, Inc.

Conditions Back Injuries Fractures, Compression Spinal Fractures

Updated 9 times since 2017 Last updated: Oct 1, 2014 Started: Jul 31, 2010 Primary completion: May 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Back Injuries and Fractures, Compression and is currently completed. Benvenue Medical, Inc. leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Benvenue Medical, Inc.

Data source: Benvenue Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Bonn, Germany , Charleston, United States , Edmond, United States , Encinitas, United States , Englewood, United States , Evanston, United States , Hershey, United States , Hinsdale, United States , Jacksonville, United States and 11 more locations